0001493152-21-009408.txt : 20210421
0001493152-21-009408.hdr.sgml : 20210421
20210421215150
ACCESSION NUMBER: 0001493152-21-009408
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210416
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaplin Adam
CENTRAL INDEX KEY: 0001858042
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 21843099
MAIL ADDRESS:
STREET 1: C/O AKERS BIOSCIENCES, INC.
STREET 2: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
3
1
ownership.xml
X0206
3
2021-04-16
1
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001858042
Kaplin Adam
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
0
1
0
0
Chief Scientific Officer
/s/ Adam Kaplin
2021-04-21